» Articles » PMID: 11685034

Superiority of Portal Venous Drainage over Systemic Venous Drainage in Pancreas Transplantation: a Retrospective Study

Overview
Journal Ann Surg
Specialty General Surgery
Date 2001 Oct 31
PMID 11685034
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare portal and systemic venous drainage of pancreas transplants and demonstrate an immunologic and survival superiority of portal venous drainage.

Summary Background Data: Traditionally, solitary pancreas transplants have been performed using systemic venous and bladder drainage, but more recently, the advantages of enteric drainage have been well documented. Although physiologic benefits for portal venous drainage have been described, the impact of portal venous drainage, especially with solitary pancreas transplants, has yet to be determined.

Methods: Since August 1995, 280 pancreas transplants with enteric duct drainage were analyzed. One hundred and seventeen were simultaneous pancreas and kidney (SPK), 63 with systemic venous drainage (SV) and 54 with portal venous drainage (PV). The remainder were solitary transplants; 97 pancreas after kidney (PAK; 42 SV and 55 PV) and 66 transplants alone (PTA; 26 SV and 40 PV). Immunosuppressive therapy was equivalent for both groups.

Results: The groups were similar with respect to recipient characteristics and HLA matching. Thirty-six month graft survival for all transplants was 79% for PV and 65% for SV (P =.008). By category, SPK graft survival was 74% for PV and 76% for SV, PAK graft survival was 70% for PV and 56% for SV, and PTA graft survival was 84% for PV and 50% for SV. The rate of at least one rejection episode was also significantly higher in the SV group. At 36 months, for all pancreas transplants, the rejection rate was 21% for PV and 52% for SV (P <.0001). For SPK, rejection rates were 9% for PV and 45% for SV. For PAK, rejection rates were 16% for PV and 65% for SV, and for PTA 36% for PV and 51% for SV. The rejection rates for kidneys following SPK were also lower in the PV group (26% versus 43% for SV). Furthermore, the grades of rejection were milder in PV for all transplants (P =.017). By multivariate analysis, portal venous drainage was the only parameter that significantly affected rejection.

Conclusion: Graft survival and rejection is superior for PV. These clinical findings are consistent with published reports of experimentally induced portal tolerance and strongly argue that PV drainage should be the procedure of choice for pancreas transplantation.

Citing Articles

Immune cell profiling in intestinal transplantation.

Suek N, Young T, Fu J Hum Immunol. 2024; 85(4):110808.

PMID: 38762429 PMC: 11283363. DOI: 10.1016/j.humimm.2024.110808.


Successful pancreas transplantation alone is associated with excellent self-identified health score and glucose control: A retrospective study from a high-volume center in the United States.

Scalea J, Pettinato L, Fiscella B, Bartosic A, Piedmonte A, Paran J Clin Transplant. 2017; 32(2).

PMID: 29226480 PMC: 6124664. DOI: 10.1111/ctr.13177.


Transplantation sites for human and murine islets.

Stokes R, Cheng K, Lalwani A, Swarbrick M, Thomas H, Loudovaris T Diabetologia. 2017; 60(10):1961-1971.

PMID: 28735354 PMC: 6448863. DOI: 10.1007/s00125-017-4362-8.


Exocrine drainage in vascularized pancreas transplantation in the new millennium.

El-Hennawy H, Stratta R, Smith F World J Transplant. 2016; 6(2):255-71.

PMID: 27358771 PMC: 4919730. DOI: 10.5500/wjt.v6.i2.255.


Bioengineering the Endocrine Pancreas: Intraomental Islet Transplantation Within a Biologic Resorbable Scaffold.

Berman D, Molano R, Fotino C, Ulissi U, Gimeno J, Mendez A Diabetes. 2016; 65(5):1350-61.

PMID: 26916086 PMC: 5384628. DOI: 10.2337/db15-1525.


References
1.
Farney A, Cho E, Schweitzer E, Dunkin B, Philosophe B, COLONNA J . Simultaneous cadaver pancreas living-donor kidney transplantation: a new approach for the type 1 diabetic uremic patient. Ann Surg. 2000; 232(5):696-703. PMC: 1421224. DOI: 10.1097/00000658-200011000-00012. View

2.
Luck R, Klempnauer J, Ehlerding G, Kuhn K . Significance of portal venous drainage after whole-organ pancreas transplantation for endocrine graft function and prevention of diabetic nephropathy. Transplantation. 1990; 50(3):394-8. DOI: 10.1097/00007890-199009000-00008. View

3.
Nghiem D, Corry R . Technique of simultaneous renal pancreatoduodenal transplantation with urinary drainage of pancreatic secretion. Am J Surg. 1987; 153(4):405-6. DOI: 10.1016/0002-9610(87)90588-5. View

4.
Lowry R, Kenick S, Lisbona R . Speculation on the pathogenesis of prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells. Transplant Proc. 1987; 19(4):3451-3. View

5.
Rao V, Burris D, Gruel S, Sollinger H, Burlingham W . Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allografts in rats. Transplantation. 1988; 45(6):1145-6. DOI: 10.1097/00007890-198806000-00032. View